From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis

被引：4
|
作者：
Thatcher, Thomas H. [1 ]
Peters-Golden, Marc [2 ]
机构：
[1] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA
[2] Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 206卷 / 05期
关键词：
THROMBOXANE A(2); RECEPTOR;
D O I：
10.1164/rccm.202205-0914ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：530 / 532
页数：4
相关论文
共 50 条
  • [21] Utility of the Major Urinary Metabolite of F2-Isoprostanes as a Biomarker to Assess Endogenous Antioxidant Status
    Milne, Ginger L.
    Dorjgochoo, Tsogzolmaa
    Roberts, L. Jackson
    Zheng, Wei
    Dai, Qi
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 : S86 - S86
  • [22] The large-scale measurement of F2-isoprostanes
    Gross, Myron D.
    Lewis, Linda
    Hayes, Jennifer
    FASEB JOURNAL, 2007, 21 (06): : A1093 - A1093
  • [23] F2-isoprostanes are not just markers of oxidative stresse
    Comporti, Mario
    Signorini, Cinzia
    Arezzini, Beatrice
    Vecchio, Daniela
    Monaco, Barbara
    Gardi, Concetta
    FREE RADICAL BIOLOGY AND MEDICINE, 2008, 44 (03) : 247 - 256
  • [24] Prolonged exercise, lymphocyte apoptosis and F2-isoprostanes
    Steensberg, A
    Morrow, J
    Toft, AD
    Bruunsgaard, H
    Pedersen, BK
    EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2002, 87 (01) : 38 - 42
  • [25] F2-isoprostanes: sensitive biomarkers of oxidative stress
    Wiswedel, I.
    FREE RADICAL RESEARCH, 2008, 42 : S42 - S42
  • [26] F2-isoprostanes in Alzheimer and other neurodegenerative diseases
    Montine, TJ
    Montine, KS
    McMahan, W
    Markesbery, WR
    Quinn, JF
    Morrow, JD
    ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (1-2) : 269 - 275
  • [27] Prolonged exercise, lymphocyte apoptosis and F2-isoprostanes
    Adam Steensberg
    Jason Morrow
    Anders Toft
    Helle Bruunsgaard
    Bente Pedersen
    European Journal of Applied Physiology, 2002, 87 : 38 - 42
  • [28] Biomarkers of Alzheimer's disease: F2-isoprostanes
    Pratico, D
    NEUROBIOLOGY OF AGING, 2004, 25 : S5 - S5
  • [29] IDENTIFICATION AND CHARACTERIZATION OF NOVEL METABOLITES OF F2-ISOPROSTANES
    Nogueira, Marina
    Sanchez, Stephanie
    Gao, Benlian
    Amin, Warda
    Thomas, Sarah
    Yang, Gong
    Milne, Ginger
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [30] Effects of F2-isoprostanes on endothelial dysfunction in an experimental hypercholesterolemia
    Ishizuka, T
    Matsui, T
    Takase, B
    Satomura, K
    Kurita, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 288A - 289A
12345